Skip to main content

Table 2 Clinical outcome of the different treatments

From: Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Characteristics

All patients

(n = 188)

Nafcillin group

(n = 91)

Glycopeptide group

(n = 97)

P value

Hospitalization period, days, median (IQR)

22.0 (14.0–39.5)

22.0 (12.0–41.0)

22.0 (15.0–36.0)

0.764c

ICU stay, days, mean ± SD

5.03 ± 14.10

3.71 ± 12.47

6.26 ± 15.44

0.217a

Persistent bacteremia, (%)

18 (9.6)

11 (12.2)

7 (7.2)

0.323b

All-cause 28-day mortality, yes (%)

27 (14.4)

7 (7.7)

20 (20.6)

0.013b

  1. Abbreviations: IQR interquartile range, ICU intensive care unit, SD standard deviation
  2. aStudent’s t-test
  3. bPearson’s χ-test
  4. cMann-Whitney U-test, median (interquartile range)